nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 10, v.46 1820-1825
越婢汤加味通过介导p38MAPK/Nrf2/ROS通路抑制氧化应激减轻UUO大鼠肾脏纤维化
基金项目(Foundation): 福建省医学创新课题(2021CXA047); 福建省中医药科技项目(2025YBB020); 龙岩市科技厅面上项目(2021LY-F7062); 福建中医药大学校管课题(XB2022159)
邮箱(Email):
DOI:
发布时间: 2026-05-22
出版时间: 2026-05-22
移动端阅读
摘要:

目的 探讨越婢汤加味基于p38丝裂原活化蛋白激酶(MAPK)/核因子红系2相关因子(Nrf)2/活性氧(ROS)对单侧输尿管结扎术(UUO)大鼠氧化应激及肾纤维化的干预机制。方法 44只SD大鼠分为对照组、模型组、马来酸依那普利组、越婢汤加味组,灌胃给药干预14 d后,通过苏木素-伊红(HE)、Masson染色检测肾脏病理变化;实时荧光定量聚合酶链式反应检测肾脏组织中α-平滑肌肌动蛋白(SMA)、E-钙黏蛋白(cadherin)、p38MAPK、Nrf2 mRNA表达量;Western印迹检测肾脏组织中α-SMA、E-cadherin、p-p38MAPK、Nrf2蛋白表达量;比色法检测肾脏组织中ROS、超氧化物歧化酶(SOD)及丙二醛(MDA)含量。结果 与对照组相比,模型组肾小球结构边界相对模糊,肾纤维化明显增多,肾组织中ROS、MDA水平、α-SMA mRNA及蛋白、p-p38MAPK蛋白表达明显上调,SOD水平、E-cadherin、Nrf2、p38MAPK mRNA表达明显下调(P<0.001);与模型组相比,依那普利组和越婢汤加味组肾小球结构边界相对清晰,肾纤维化明显缓解;依那普利组肾组织中MDA、ROS、α-SMA和p-p38MAPK蛋白明显下调,SOD水平、E-cadherin、Nrf2、p38MAPK mRNA及E-cadherin、Nrf2蛋白明显上调(P<0.05,P<0.01,P<0.001);越婢汤加味组肾组织中MDA、ROS水平及p-p38MAPK蛋白表达显著下降,E-cadherin、Nrf2 mRNA及蛋白表达明显升高(P<0.05,P<0.01)。结论 越婢汤加味可以改善UUO所致肾病大鼠肾损伤,其机制可能与调控p38MAPK/Nrf2/ROS信号通路,阻止氧化应激反应,抑制肾纤维化有关。

Abstract:

KeyWords:
参考文献

1 Livingston MJ,Shu S,Fan Y,et al.Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis[J].Autophagy,2023;19(1):256-77.

2 Takahashi Y,Watanabe M,Hiura K,et al.Positive correlation between renal tubular flattening and renal tubular injury/interstitial fibrosis in murine kidney disease models[J].J Vet Med Sci,2021;83(3):397-402.

3 Loomba R,Abdelmalek MF,Armstrong MJ,et al.Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis:a randomised,placebo-controlled phase 2 trial[J].Lancet Gastroenterol Hepatol,2023;8(6):511-22.

4 Aslam Saifi M,Hirawat R,Godugu C.Lactoferrin-decorated cerium oxide nanoparticles prevent renal injury and fibrosis[J].Biol Trace Elem Res,2023;201(4):1837-45.

5 Tang G,Li S,Zhang C,Chen H,et al.Clinical efficacies,underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management[J].Acta Pharm Sin B,2021;11(9):2749-67.

6 Wang X,Song R,Li Z.Salviolone protects against high glucose-induced proliferation,oxidative stress,inflammation,and fibrosis of human renal mesangial cells by upregulating membrane metalloendopeptidase expression[J].Chem Biol Drug Des,2023;101(4):819-28.

7 Liu Y,Zhang M,Zhong H,et al.LncRNA SNHG16 regulates RAS and NF-κB pathway-mediated NLRP3 inflammasome activation to aggravate diabetes nephropathy through stabilizing TLR4[J].Acta Diabetol,2023;60(4):563-77.

8 李婷婷,周圆,徐琳,等.越婢汤调控肾脏毛细血管通透性对阿霉素肾病大鼠水肿的干预作用[J].中成药,2023;45(3):748-55.

9 姚木铭,杨达龙,李秋玲,等.越婢汤加味对慢性肾小球肾炎患者血清胱抑素、尿微量蛋白及免疫功能的影响[J].四川中医,2020;38(10):141-4.

10 吕艳杭,姚木铭,杨达龙,等.越婢汤加味对慢性肾功能衰竭患者NF-κB信号通路的影响[J].中医学报,2023;38(8):1593-8.

11 阮陶仁,高洪燕,邢茂,等.基于Wnt通路探讨生地黄水提物对单侧输尿管梗阻大鼠肾纤维化的作用机制[J].中药新药与临床药理,2021;32(8):1101-8.

12 Jiang X,Wu Q,Opoku YK,et al.Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation,fibrosis and oxidative stress[J].Basic Clin Pharmacol Toxicol,2022;131(6):474-86.

13 Zhang HF,Liu HM,Xiang JY,et al.Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation[J].Acta Pharmacol Sin,2023;44(5):1051-65.

14 朱婧婧,何伟明,高坤,等.衰老与肾纤维化之间相关机制的研究进展[J].中华中医药学刊,2021;39(3):124-8.

15 廖永丽,李均.基于Hedgehog信号通路的中药抗肾纤维化研究进展[J].医学综述,2021;27(16):3137-42.

16 Jha JC,Dai A,Garzarella J,et al.Independent of renox,NOX5 promotes renal inflammation and fibrosis in diabetes by activating ROS-sensitive pathways[J].Diabetes,2022;71(6):1282-98.

17 Aranda-Rivera AK,Cruz-Gregorio A,Aparicio-Trejo OE,et al.Redox signaling pathways in unilateral ureteral obstruction(UUO)-induced renal fibrosis[J].Free Radic Biol Med,2021;172:65-81.

18 Chen ZQ,Sun XH,Li XJ,et al.Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway[J].Acta Pharmacol Sin,2020;41(12):1587-96.

19 陈冉,杨金月,于国泳.中药基于抗氧化应激及其下游相关因子延缓糖尿病肾病的研究进展[J].环球中医药,2022;15(8):1477-85.

20 陈诺,金华,呼琴,等.清肾颗粒对腺嘌呤致肾纤维化大鼠Nrf2/ARE信号通路及氧化应激的干预作用[J].中医药临床杂志,2023;35(5):976-82.

21 Liu B,Hu D,Zhou Y,et al.Exosomes released by human umbilical cord mesenchymal stem cells protect against renal interstitial fibrosis through ROS-mediated P38MAPK/ERK signaling pathway[J].Am J Transl Res,2020;12(9):4998-5014.

22 Xu R,Chen MY,Liang W,et al.Zinc deficiency aggravation of ROS and inflammatory injury leading to renal fibrosis in mice[J].Biol Trace Elem Res,2021;199(2):622-32.

23 黄婷,邓博,程志强.平肺口服液对急性放射性肺损伤大鼠肺损伤及p38MAPK/Nrf2/HO-1信号通路的影响[J].现代中西医结合杂志,2022;31(21):2934-8,2984.

24 符健,高艺,林锋,等.和厚朴酚对大鼠肝纤维化及P38MAPK/Nrf2信号通路的影响[J].中西医结合肝病杂志,2021;31(3):246-9.

25 Wang D,Li Y,Dai L,et al.1,2,3,4,6-penta-O-galloyl-β-D-glucose alleviates inflammation and oxidative stress in diabetic nephropathy rats through MAPK/NF-κB and ERK/Nrf2/HO-1 signaling pathways[J].Exp Ther Med,2022;24(4):639.

26 杨少宁,周锦纹,陈丹倩,等.基于TGF-β1/p38MAPK通路探讨益血降浊汤对UUO大鼠肾纤维化的作用机制[J].云南中医中药杂志,2019;40(10):60-7.

27 陶春鹤,张玉笛,轩晨,等.芪精益肾汤对糖尿病肾病大鼠Nrf2/HO-1信号通路的作用及机制研究[J].中国中西医结合杂志,2022;42(4):455-63.

基本信息:

中图分类号:R285.5

引用信息:

[1]吕艳杭,姚木铭,杨达龙,等.越婢汤加味通过介导p38MAPK/Nrf2/ROS通路抑制氧化应激减轻UUO大鼠肾脏纤维化[J].中国老年学杂志,2026,46(10):1820-1825.

基金信息:

福建省医学创新课题(2021CXA047); 福建省中医药科技项目(2025YBB020); 龙岩市科技厅面上项目(2021LY-F7062); 福建中医药大学校管课题(XB2022159)

发布时间:

2026-05-22

出版时间:

2026-05-22

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文